219 related articles for article (PubMed ID: 33273988)
1. Systematic Investigation of mRNA
Jiang M; Lu Y; Duan D; Wang H; Man G; Kang C; Abulimiti K; Li Y
Dis Markers; 2020; 2020():8833438. PubMed ID: 33273988
[TBL] [Abstract][Full Text] [Related]
2. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract][Full Text] [Related]
4. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
[No Abstract] [Full Text] [Related]
5. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.
Gao Y; Teng J; Hong Y; Qu F; Ren J; Li L; Pan X; Chen L; Yin L; Xu D; Cui X
Med Oncol; 2015 Jul; 32(7):518. PubMed ID: 26036682
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy.
Liu Z; Zhong J; Zeng J; Duan X; Lu J; Sun X; Liu Q; Liang Y; Lin Z; Zhong W; Wu W; Cai C; Zeng G
Front Immunol; 2021; 12():735170. PubMed ID: 34531875
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of m
Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
[TBL] [Abstract][Full Text] [Related]
9. N
von Hagen F; Gundert L; Strick A; Klümper N; Schmidt D; Kristiansen G; Tolkach Y; Toma M; Ritter M; Ellinger J
Mol Carcinog; 2021 May; 60(5):354-362. PubMed ID: 33755994
[TBL] [Abstract][Full Text] [Related]
10. RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma.
Lu D; Mihoayi M; Ablikim Y; Arikin A
Aging (Albany NY); 2024 Mar; 16(7):5929-5948. PubMed ID: 38535990
[TBL] [Abstract][Full Text] [Related]
11. Multiomics analysis identifies key genes and pathways related to N6-methyladenosine RNA modification in ovarian cancer.
Xu H; Li X; Wang S; Li F; Gao J; Yan L; Zhu L
Epigenomics; 2021 Sep; 13(17):1359-1383. PubMed ID: 34550011
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of METTL14 mediates the elevation of PERP mRNA N
Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
[TBL] [Abstract][Full Text] [Related]
13. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.
Ying Y; Wu Y; Zhang F; Tang Y; Yi J; Ma X; Li J; Chen D; Wang X; Liu X; Liu B; Luo J; Zheng X; Xie L
Mol Cancer; 2024 Apr; 23(1):79. PubMed ID: 38658974
[TBL] [Abstract][Full Text] [Related]
14. The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer.
Wang J; Lin H; Zhou M; Xiang Q; Deng Y; Luo L; Liu Y; Zhu Z; Zhao Z
Future Oncol; 2020 Oct; 16(30):2421-2432. PubMed ID: 32687727
[No Abstract] [Full Text] [Related]
15. METTL16 exerts an m
Su R; Dong L; Li Y; Gao M; He PC; Liu W; Wei J; Zhao Z; Gao L; Han L; Deng X; Li C; Prince E; Tan B; Qing Y; Qin X; Shen C; Xue M; Zhou K; Chen Z; Xue J; Li W; Qin H; Wu X; Sun M; Nam Y; Chen CW; Huang W; Horne D; Rosen ST; He C; Chen J
Nat Cell Biol; 2022 Feb; 24(2):205-216. PubMed ID: 35145225
[TBL] [Abstract][Full Text] [Related]
16. m
Wang Q; Zhang Q; Huang Y; Zhang J
DNA Cell Biol; 2020 Oct; 39(10):1767-1778. PubMed ID: 32833542
[TBL] [Abstract][Full Text] [Related]
17. Deciphering N
Zhu J; Wang M; Hu D
Biomed Res Int; 2020; 2020():2514230. PubMed ID: 32258108
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
19. Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells.
Yu X; Zheng B; Chai R
Biosci Rep; 2014 Dec; 34(6):e00161. PubMed ID: 25370813
[TBL] [Abstract][Full Text] [Related]
20. Contributions and prognostic values of m
Liu Y; Guo X; Zhao M; Ao H; Leng X; Liu M; Wu C; Ma J; Zhu J
J Cell Physiol; 2020 Sep; 235(9):6043-6057. PubMed ID: 32052446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
